Oral morphine in advanced cancer
Publication details: Beaconsfield Beaconsfield Publishers 1997Edition: 3rdDescription: 42; ill.,bibl.; BookFindISBN:- 0906584450
Item type | Home library | Class number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|
Book | Newcomb Library at Homerton Healthcare Shelves | QZ 267 TWY (Browse shelf(Opens below)) | Available | HOM2646 |
Browsing Newcomb Library at Homerton Healthcare shelves, Shelving location: Shelves Close shelf browser (Hides shelf browser)
No cover image available | ||||||||
QZ 266 WYA Cancer and cancer care | QZ 267 ROY Coping with nausea and vomiting: a guide for cancer patients | QZ 267 TWY Oral morphine in advanced cancer | QZ 267 TWY Oral morphine in advanced cancer | QZ 269 HOL Radiotherapy: a guide for practice | QZ 4 AND Anderson's Pathology volume 1 | QZ 4 AND Anderson's pathology, 2 v. |
Oral morphine in advanced cancer; response to morphine; starting treatment with morphine; coping with unwanted effects; more questions about morphine; other important uses of morphine.
Paperback
The regular use of morphine by mouth has done much to improve the management of pain in far-advanced cancer. This booklet serves as an introduction to the much wider subject of cancer pain management, and should be of interest to doctors and nurses working in this field. A parallel booklet is also available called ""Oral Morphine: Information for Patients, Families and Friends"". This new edition has been prepared in the light of several developments since 1984. Firstly, the campaign by the World Health Organization to improve cancer pain management globally. This emphasizes that analgesic drugs, and particularly oral morphine, are the mainstay of management. Secondly, a greater awareness of the need to distinguish between morphine-responsive and morphine-resistant pain. Third, the availability of slow-release tablets of morphine. The material in this booklet also appears in ""Therapeutics in Terminal Cancer"" (second edition, Churchill Livingstone, 1989).
There are no comments on this title.